1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SIDT2 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA CABP4 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA CFAP45 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA BICD1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA CORO1C CTRPv2 pan-cancer AAC -0.099 0.01
mRNA CREBZF CTRPv2 pan-cancer AAC -0.092 0.01
mRNA MAGED4B CTRPv2 pan-cancer AAC -0.099 0.01
mRNA CYSLTR1 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA CCSAP CTRPv2 pan-cancer AAC 0.092 0.01
mRNA PDE5A CTRPv2 pan-cancer AAC -0.095 0.01
Download CSV